期刊文献+

胆固醇吸收抑制剂——依折麦布 被引量:5

下载PDF
导出
摘要 依折麦布是一种新型调酯药物,它与小肠壁上特异的转运蛋白NPC1L1结合,选择性地强效抑制小肠胆固醇和植物甾醇的吸收。口服吸收迅速,不影响脂溶性维生素、甘油三酯(TG)、脂肪酸、胆汁酸、孕酮、乙炔雌醇等的吸收,不增加胆汁酸的分泌,耐受性好。与临床上广泛应用的他汀类、非诺贝特等在药代动力学上无显著的相互作用。可单独应用,也可和他汀类药物或贝特类药物合用。
作者 李云建
出处 《医学理论与实践》 2012年第11期1304-1305,共2页 The Journal of Medical Theory and Practice
  • 相关文献

参考文献16

  • 1陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社.2008:251.
  • 2Turley SD. Dietary cholesterol ang the mechanisms of choles- terol absorption[J]. Eur Herr J Suppl, 1999(Suppl S): S29- S35.
  • 3Lichtension AH. Intestinal cholesterol metabolism[J]. Ann Med,1990,22:29-52.
  • 4Turley SD, Dietschy JM. The intestinal absorption of biliary ang dietary cholesterol as a drug target lowering the plasma cholesterol level [J]. Prey Cardiol, 2003,6: 29-33.
  • 5Kesanieni TA Miettinen TA. Cholesterol absorption effeiciency regulates plasma cholesterol level in the Finishi population[J].Eur J Clin Intest,1987,17:391-395.
  • 6Kajinarni K,Takekoshi N. Cholesterol absorption inhibitors in development as potential therapeutics [J]. Exp Opin Investig Drugs, 2002,11 (6) : 831-835.
  • 7Miettinen TA. Cholesterol absorption inhibition: a strategy for cholesterol-lowering therapy[J].Int J Clin Pratt, 2001, 55 (10) :710-716.
  • 8白元,秦永文.新型降脂药——依折麦布的研究进展[J].药学服务与研究,2007,7(3):187-190. 被引量:15
  • 9Sudhop T, Lutjohann D, Kodal A, et al. Inhibition of intestinal cholesterol absorption by ezetimibe in humans[J]. Cieculation, 2002,106:1943-1948.
  • 10Bays HE, Noore PB, Drehobl MA, et al. Effectiveness and tol- erability of ezetimibe in patients with primary hypercholester- olemia: pooled analysis of two phase II studies[J]. Clin Ther, 2001,23 : 1209-1230.

二级参考文献1

共引文献1825

同被引文献53

  • 1国家药典委员会.中国药典·二部[s].北京:中国医药出版社,2010:附录35,附录H.
  • 2Bays H, Sapres A, Taggart IW. Long-term (48- week ) safety of ezetimibe 10rag/day coadministered with simvastatin compared to simvastatin alone in patientq with primm7 hypercholesterolemia[J].Curr Med Res Opin, 2008,24 ( 10 ): 2953-2966.
  • 3Masana L, Mata P, Gagne C.L0ng-term safety and, tolerability pro-files andlipid-modifying eficacy of ezetinfibe coadministered with ongoing simvastatin treatment: A multicenter, randomized, doubleo blind : placebo, controlled,48-Week extension study[J].Clin Ther,2005,27 ( 2 ) : 174-184.
  • 4ICH Q2A.Test on Validation of Analytical Procedures.1996.
  • 5ICH Q2B.Validation of Analytical Procedures: Methodology, 1996.
  • 6化学药物质量控制分析方法验证技术指导原则[s].2005:3.
  • 7FDA.Guidance for Industry: analytical procedures and methods validation, chemistry, manufacturing, and controls documentation ( Draft ), 2000,8,.
  • 8熊祯,翟所迪,陈凤荣.新型血脂调节药——依折麦布[J].中国新药与临床杂志,2007,26(11):864-868. 被引量:23
  • 9Wang Y, Zhang H, Huang W, et al. 2-Azetidinone derivatives: design, synthesis and evaluation of cholesterol absorption inhibitros[J]. European journal of medicinal chemistry 2009, 44(4): 1638-1643.
  • 10Garcia-Calvo M, Lisnock JM, Bull HG, et al. The target of ezetimibe is Niemann-Pick Cl-like 1 (NPCILI)[J]. Proceedings of the NationalAcademy of Sciences of the United States of America, 2005, 102(23): 8132-8137.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部